Market Cap 98.66B
Revenue (ttm) 372.81B
Net Income (ttm) 4.61B
EPS (ttm) N/A
PE Ratio 11.35
Forward PE 11.69
Profit Margin 1.24%
Debt to Equity Ratio 0.90
Volume 12,106,500
Avg Vol 7,864,146
Day's Range N/A - N/A
Shares Out 1.27B
Stochastic %K 15%
Beta 0.48
Analysts Strong Sell
Price Target $94.22

Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management serv...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
WallStreetBuyDip
WallStreetBuyDip Dec. 21 at 6:49 AM
$GDRX trading at $3 with volume 60% above average, while $CVS priced at $78 with volume 32% above average. GDRX showing 20x cheaper than CVS but with much higher volume. Are investors favoring the lower-priced play in this PharmaRetail sector?
0 · Reply
1iquid
1iquid Dec. 21 at 6:13 AM
💎 Liquid® Live Actionable Trade Asset: $CVS Contracts: $CVS January 15, 2027 $80 Calls Scale in: $7.94- $9.71 Scale out: $30.89-$52.95 Profit Potential : 405% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
DD_First
DD_First Dec. 21 at 12:36 AM
$SPY $QQQ $MRK $DD.X $CVS Not bullish, so this is pharma news is bearish Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 20 at 5:51 PM
$CVS This ticker is currently trading around $77.70, with a recent high at $83.05 and a low near $43.95. Average volume is approximately 9,150,000. Looks like it's been consolidating in the mid $70S range, with some recent spikes in volume.
0 · Reply
1iquid
1iquid Dec. 20 at 8:40 AM
OptionWizards Tip (education only): Avoid holding short options on CVS, CME, or SO through earnings, as volatility can cause unpredictable price swings. $CVS $CME $SO Not financial advice.
0 · Reply
KingdomTrading
KingdomTrading Dec. 20 at 1:39 AM
$CVS Current: $77.72 Entry: $76.89 Target: $64.18 Potential: -16.5% Horizon: 7 days The content provided on https://stocksurger.com/ is for informational purposes only and does not constitute a recommendation to buy or sell any security.
0 · Reply
Bazzzigar
Bazzzigar Dec. 19 at 11:44 PM
$CVS more drop after Trump deal..
0 · Reply
1Knevrenuff
1Knevrenuff Dec. 19 at 10:32 PM
$CVS ...14 drug companies will be putting cheaper meds on Trump.rx...
0 · Reply
AlphaBullRider
AlphaBullRider Dec. 19 at 9:02 PM
$UNH Darn Mr. TACO took my green profit to red loss in final hour. :-( $CNC $ELV $HUM $CVS
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 19 at 7:51 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CVS $77.00 Put · DEC 26, 2025 Exp Entry Price: $0.65 - $0.68 Exit Price Target: $1.33 Profit Margin: +105% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Latest News on CVS
Final Trade: ETH, GM, CVS, NFLX

Dec 16, 2025, 6:21 PM EST - 4 days ago

Final Trade: ETH, GM, CVS, NFLX

GM NFLX ETH


Cramer's Stop Trading: CVS Health

Dec 10, 2025, 10:36 AM EST - 10 days ago

Cramer's Stop Trading: CVS Health


Buy Or Fear CVS Stock At $78?

Dec 10, 2025, 9:00 AM EST - 10 days ago

Buy Or Fear CVS Stock At $78?


Cramer's Mad Dash --- CVS Health

Dec 9, 2025, 9:48 AM EST - 11 days ago

Cramer's Mad Dash --- CVS Health


CVS to pay $37.8 million to settle claims over insulin pens

Dec 2, 2025, 10:14 AM EST - 18 days ago

CVS to pay $37.8 million to settle claims over insulin pens


Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS

Dec 1, 2025, 8:00 AM EST - 19 days ago

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS


These outperforming stocks are still cheap heading into 2026

Nov 27, 2025, 2:15 PM EST - 23 days ago

These outperforming stocks are still cheap heading into 2026

MU NEM


Curaechoice Selects CVS Caremark at its PBM

Nov 24, 2025, 10:58 AM EST - 26 days ago

Curaechoice Selects CVS Caremark at its PBM


CVS Health Names David Joyner Chair of the Board of Directors

Nov 20, 2025, 4:05 PM EST - 4 weeks ago

CVS Health Names David Joyner Chair of the Board of Directors


Aetna Launches Leading Edge Conversational AI Navigation

Nov 18, 2025, 11:00 AM EST - 4 weeks ago

Aetna Launches Leading Edge Conversational AI Navigation


CVS Health to hold Investor Day on December 9, 2025

Nov 10, 2025, 9:00 AM EST - 5 weeks ago

CVS Health to hold Investor Day on December 9, 2025


CVS Health: Undervalued And Ripe For Growth

Nov 3, 2025, 8:00 AM EST - 6 weeks ago

CVS Health: Undervalued And Ripe For Growth


CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 10:21 AM EDT - 7 weeks ago

CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript


CVS Posts Loss on Write-Down, Boosts Guidance

Oct 29, 2025, 6:42 AM EDT - 7 weeks ago

CVS Posts Loss on Write-Down, Boosts Guidance


WallStreetBuyDip
WallStreetBuyDip Dec. 21 at 6:49 AM
$GDRX trading at $3 with volume 60% above average, while $CVS priced at $78 with volume 32% above average. GDRX showing 20x cheaper than CVS but with much higher volume. Are investors favoring the lower-priced play in this PharmaRetail sector?
0 · Reply
1iquid
1iquid Dec. 21 at 6:13 AM
💎 Liquid® Live Actionable Trade Asset: $CVS Contracts: $CVS January 15, 2027 $80 Calls Scale in: $7.94- $9.71 Scale out: $30.89-$52.95 Profit Potential : 405% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
DD_First
DD_First Dec. 21 at 12:36 AM
$SPY $QQQ $MRK $DD.X $CVS Not bullish, so this is pharma news is bearish Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 20 at 5:51 PM
$CVS This ticker is currently trading around $77.70, with a recent high at $83.05 and a low near $43.95. Average volume is approximately 9,150,000. Looks like it's been consolidating in the mid $70S range, with some recent spikes in volume.
0 · Reply
1iquid
1iquid Dec. 20 at 8:40 AM
OptionWizards Tip (education only): Avoid holding short options on CVS, CME, or SO through earnings, as volatility can cause unpredictable price swings. $CVS $CME $SO Not financial advice.
0 · Reply
KingdomTrading
KingdomTrading Dec. 20 at 1:39 AM
$CVS Current: $77.72 Entry: $76.89 Target: $64.18 Potential: -16.5% Horizon: 7 days The content provided on https://stocksurger.com/ is for informational purposes only and does not constitute a recommendation to buy or sell any security.
0 · Reply
Bazzzigar
Bazzzigar Dec. 19 at 11:44 PM
$CVS more drop after Trump deal..
0 · Reply
1Knevrenuff
1Knevrenuff Dec. 19 at 10:32 PM
$CVS ...14 drug companies will be putting cheaper meds on Trump.rx...
0 · Reply
AlphaBullRider
AlphaBullRider Dec. 19 at 9:02 PM
$UNH Darn Mr. TACO took my green profit to red loss in final hour. :-( $CNC $ELV $HUM $CVS
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 19 at 7:51 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CVS $77.00 Put · DEC 26, 2025 Exp Entry Price: $0.65 - $0.68 Exit Price Target: $1.33 Profit Margin: +105% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Stocks4thought
Stocks4thought Dec. 19 at 6:16 PM
$CVS I'm thinking that- we may be shielded from market disdain and government scrutiny. All this talk about insurance stocks up 1600%- not in this town? But our insurance is under the hood of a retail stock?
0 · Reply
sam7t
sam7t Dec. 19 at 4:35 PM
$TDOC the only hope is for someone like $HIMS or $UNH or $AMZN or $CVS to acquire teladog. or you will see the board and leadership continue to keep this afloat with the sole purpose of filling their deep greedy pockets. watch chuck divita come back with more trash next ER
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:23 PM
Actionable Trade Alert: $CVS Market Context: $CVS is currently trading at $77.79, showing potential for upward movement based on recent metrics. The RSI of 42.45 indicates that the stock is nearing oversold conditions, suggesting a possible reversal. The price is below both the 30-day (78.26) and 50-day (79.01) moving averages, indicating bearish sentiment, but the proximity to the 60-day low of 73.83 may provide support. Directional Bias: Given the RSI and the current price near the lower end of the 60-day range, there is a bullish bias for a potential rebound. Trade Plan: - Suggested Entry: $78.00 - Stop Loss: $75.50 (risking $2.50) - Take Profit Targets: 1. TP1: $80.00 (ROI: 25.6%) 2. TP2: $82.00 (ROI: 50.0%) 3. TP3: $84.00 (ROI: 66.7%) The targets are set to capitalize on the potential rebound while ensuring a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
roejohn
roejohn Dec. 18 at 5:43 PM
$CVS pharmacy should begin educating patients about the lone- star tick . We need to start a program . Apparently , there will be a vaccine but not in 2026. Plant based diets is the only preventative , for example BYND . However, many prepare these veggie meals ! Dairy and excipients in medication must be discussed. CVS , you have monopolized the industry so you are in the best position to help prevent severe reactions and death !
0 · Reply
DD_First
DD_First Dec. 18 at 1:26 PM
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:20 PM
JP Morgan updates rating for CVS Health ( $CVS ) to Overweight, target set at 93 → 101.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:11 PM
Health insurers are back in the driver’s seat — and 2026 could be the payoff 🩺📈 Pricing control and margin visibility are improving, putting $UNH, $CVS, and $CNC back in focus as managed care regains its pulse and investor attention. See why these three insurers are lining up as 2026 plays 👉 https://www.zacks.com/stock/news/2805506/health-insurers-now-get-a-pulse-3-stocks-to-jump-in-2026?cid=sm-stocktwits-2-2805506-teaser-25196&ADID=SYND_STOCKTWITS_TWEET_2_2805506_TEASER_25196
0 · Reply
Gigatheta
Gigatheta Dec. 17 at 4:15 PM
$CVS no real buyers No hedge funds want this 200+ PE ratio No real assets Corner store crash out 2028 $15 SHARE PRICE TARGET
1 · Reply
Gigatheta
Gigatheta Dec. 17 at 3:19 PM
$SPY noobs getting crushed Short UVXY LONG SVIX SHORT $CVS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:10 AM
Actionable Trade Alert for $CVS: Market Context: $CVS is currently trading at $78.07, positioned between its 60-day high of $85.15 and low of $73.83. The RSI at 48.93 indicates a neutral momentum, suggesting potential for upward movement as it approaches oversold levels. Directional Bias: The price is slightly below the 30-day moving average (MA30) of $78.28 and the 50-day moving average (MA50) of $78.98, indicating a potential bullish reversal if it breaks above these levels. Trade Plan: - Suggested Entry: $78.50 (above MA30) - Stop Loss: $76.50 (below recent support) - Take Profit Targets: 1. $81.00 (target 1, approx. 3.2% gain) 2. $83.00 (target 2, approx. 5.9% gain) 3. $91.50 (target 3, approx. 17.2% gain) This plan offers a favorable risk-reward ratio, capitalizing on potential upward momentum while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
parcha
parcha Dec. 17 at 12:16 AM
Final Trade: ETH, GM, CVS, NFLX $ETH $GM $CVS $NFLX https://www.cnbc.com/video/2025/12/16/final-trade-eth-gm-cvs-nflx.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 16 at 7:46 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CVS $77.00 Put · DEC 26, 2025 Exp Entry Price: $0.80 - $0.87 Exit Price Target: $1.79 Profit Margin: +124% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply